Cargando…

Network pharmacology and molecular docking predictions of the active compounds and mechanism of action of Huangkui capsule for the treatment of idiopathic membranous nephropathy

BACKGROUND: Huangkui Capsule is a single herbal concoction prepared from the flower of Abelmoschus manihot, which is used to treat idiopathic membranous nephropathy (IMN), a frequent pathologically damaging kidney condition. It has been widely utilized to treat a variety of renal disorders, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Meng, Xiang, Yongjing, Li, Zhengsheng, Xie, Juan, Wen, Fulong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article: Clinical Trial/Experimental Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508523/ https://www.ncbi.nlm.nih.gov/pubmed/37713831 http://dx.doi.org/10.1097/MD.0000000000035214

Ejemplares similares

Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis
por: An, Wenrong, et al.
Publicado: (2021)

Clinical Efficacy of Huangkui Capsule Plus Methylprednisolone for Immunoglobulin A Nephropathy and Its Effect on Renal Function and Serum Inflammatory Factors
por: Yuan, Lili, et al.
Publicado: (2023)

Clinical Efficacy of Huangkui Capsule plus Methylprednisolone in the Treatment of Nephropathy and the Effect on Urinary Protein and Serum Inflammatory Factors in Patients
por: Wan, Weibo, et al.
Publicado: (2022)

Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway
por: Pei, Shuwen, et al.
Publicado: (2021)

Retracted: Clinical Efficacy of Huangkui Capsule plus Methylprednisolone in the Treatment of Nephropathy and the Effect on Urinary Protein and Serum Inflammatory Factors in Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy
por: Wu, Wei, et al.
Publicado: (2018)

Based on network pharmacology and molecular docking to predict the mechanism of TMDZ capsule in the treatment of IS
por: Yang, Fengjiao, et al.
Publicado: (2023)

Huangkui Capsule Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Macrophage Activation by Suppressing Inflammation and Oxidative Stress in Mice
por: Deng, Jinfang, et al.
Publicado: (2021)

Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology
por: Shi, Honghong, et al.
Publicado: (2022)

Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways
por: Gu, Li-fei, et al.
Publicado: (2020)

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
por: Hu, Yaling, et al.
Publicado: (2022)

Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis
por: Fan, Jiashuang, et al.
Publicado: (2022)

Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022)

Huangkui lianchang decoction attenuates experimental colitis by inhibiting the NF-κB pathway and autophagy
por: Cheng, Xudong, et al.
Publicado: (2022)

Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology
por: Li, Haoran, et al.
Publicado: (2020)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Effective Material Basis and Mechanism Analysis of Compound Banmao Capsule against Tumors Using Integrative Network Pharmacology and Molecular Docking
por: He, Tian-Mu, et al.
Publicado: (2021)

Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy
por: Zhang, Qiqiang, et al.
Publicado: (2020)

Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
por: Kennedy, Claire, et al.
Publicado: (2013)

Idiopathic Membranous Nephropathy and Treatment Related Complications
por: Uncanin, Snezana, et al.
Publicado: (2020)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Huangkui Lianchang Decoction Ameliorates DSS-Induced Ulcerative Colitis in Mice by Inhibiting the NF-kappaB Signaling Pathway
por: He, Zongqi, et al.
Publicado: (2019)

Potential molecular mechanisms of Erlongjiaonang action in idiopathic sudden hearing loss: A network pharmacology and molecular docking analyses
por: Zhao, He, et al.
Publicado: (2023)

Differential Expression of Urinary Exosomal Small RNAs in Idiopathic Membranous Nephropathy
por: Zhang, Jinshi, et al.
Publicado: (2020)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
por: Zhang, Mingxu, et al.
Publicado: (2021)

Molecular mechanism underlying the hypolipidemic effect of Shanmei Capsule based on network pharmacology and molecular docking
por: Wang, Qian, et al.
Publicado: (2021)

A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression
por: Yang, Lin, et al.
Publicado: (2023)

Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
por: Bao, Neng, et al.
Publicado: (2023)

Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial
por: Li, Yi, et al.
Publicado: (2020)

Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology
por: Zhang, Jian, et al.
Publicado: (2018)

Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013)

The Unpredictability of Idiopathic Membranous Nephropathy: An Illustrative Case Report
por: Levin, Murray L., et al.
Publicado: (2018)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Idiopathic membranous nephropathy in children: A case report
por: Cui, Kun-Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bvpfls8trei4o7ojgideet3m3l